View Older Stories View More Recent Stories

Nov 14, 2024 10:12AM Form SC 13G OnKure Therapeutics, Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Nov 14, 2024 10:07AM Form SC 13G Bakkt Holdings, Inc. Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Nov 14, 2024 10:01AM Form SC 13G BIORA THERAPEUTICS, INC. Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Nov 8, 2024 09:02AM Form SC 13G/A CompoSecure, Inc. Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Nov 8, 2024 09:00AM Form SC 13G/A CAPRICOR THERAPEUTICS, Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Nov 8, 2024 08:33AM Form SC 13G/A SELLAS Life Sciences Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Nov 8, 2024 08:31AM Form SC 13G/A Iron Horse Acquisitions Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Nov 8, 2024 07:16AM Form 13F-HR HIGHBRIDGE CAPITAL MANAG For: Sep 30
Oct 25, 2024 10:30AM Form SC 13G EQV Ventures Acquisition Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Oct 25, 2024 10:16AM Form SC 13G Inmune Bio, Inc. Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Oct 25, 2024 10:15AM Form SC 13G Fortress Biotech, Inc. Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Oct 25, 2024 10:00AM Form SC 13G Graf Global Corp. Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Oct 25, 2024 10:00AM Form SC 13G Star Holdings Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Oct 25, 2024 09:46AM Form SC 13G DT Cloud Star Acquisitio Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Oct 25, 2024 09:45AM Form SC 13G GENELUX Corp Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Oct 25, 2024 09:33AM Form SC 13G Karyopharm Therapeutics Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Oct 25, 2024 09:32AM Form SC 13G Pinstripes Holdings, Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Oct 25, 2024 09:15AM Form SC 13G Matinas BioPharma Holdin Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Oct 1, 2024 06:11PM Form SC 13D Vertex Energy Inc. Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Sep 27, 2024 10:00AM CoinFund Grows Team with Three New Investors for Early-Stage Seed and Ventures Funds, Announces New Head of Business Development & Investor Relations
Sep 12, 2024 01:00AM Santhera Announces Half-Year 2024 Financial Results and Provides Corporate Update
Sep 12, 2024 01:00AM Santhera Announces Half-Year 2024 Financial Results and Provides Corporate Update
Aug 13, 2024 03:19PM Form N-PX HIGHBRIDGE CAPITAL MANAG For: Jun 30
Aug 13, 2024 01:00AM Santhera Closes Financings and Secures Funds to Reach Break-Even Expected in 2026
Aug 12, 2024 11:36AM Form 13F-HR HIGHBRIDGE CAPITAL MANAG For: Jun 30
Aug 7, 2024 04:02PM Omeros Corporation Reports Second Quarter 2024 Financial Results
Jul 30, 2024 09:30AM MCAP Announces Senior Hire in QwickRoute Division
Jul 25, 2024 11:30AM CoinFund Expands Best-in-Class Team, Launches Podcast as Firm Commemorates Nine Years of Service
Jul 1, 2024 06:01AM Inseego Corp. (INSG) Announces Debt Reduction and Restructuring
Jul 1, 2024 06:00AM Inseego Announces Debt Reduction and Restructuring Transactions of Convertible Notes due 2025
Jun 18, 2024 08:00AM Gamida Cell Announces New Leadership Under Ownership of Highbridge Capital Management
Jun 18, 2024 01:15AM Santhera Secures up to CHF 69 million in Royalty and Debt Financing to Fund Operations to Cash Flow Break-Even
Jun 18, 2024 01:15AM Santhera Secures up to CHF 69 million in Royalty and Debt Financing to Fund Operations to Cash Flow Break-Even
Jun 3, 2024 09:00AM Omeros Corporation Further Strengthens its Balance Sheet through Series of Financing Transactions Extending Maturity on a Majority of its Outstanding Debt into 2028
May 28, 2024 09:41AM Mithra postpones its annual general meeting
May 10, 2024 11:07AM Form 13F-HR HIGHBRIDGE CAPITAL MANAG For: Mar 31
May 8, 2024 07:30AM Karyopharm Therapeutics (KPTI) Announces Significant Refinancing Transactions and Amended Royalty Agreement Extending Vast Majority of Its Debt Maturities into 2028 and 2029
May 8, 2024 07:30AM Karyopharm Announces Significant Refinancing Transactions and Amended Royalty Agreement Extending Vast Majority of Its Debt Maturities into 2028 and 2029
May 3, 2024 11:30AM Mithra enters into exclusive negotiations with Gedeon Richter and secures continued funding in the context of its monetization process
Apr 22, 2024 11:13AM Norton Rose Fulbright continues Chicago growth with investment funds partner
Mar 27, 2024 07:02AM Gamida Cell (GMDA) Announces Commencement of Restructuring Process Supported by Highbridge Capital Management
Mar 27, 2024 07:00AM Gamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital Management
Mar 27, 2024 07:00AM Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update
Feb 13, 2024 09:15AM Form SC 13G Gorilla Technology Group Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Feb 12, 2024 12:12PM Form 13F-HR HIGHBRIDGE CAPITAL MANAG For: Dec 31
Feb 7, 2024 03:02PM Form SC 13G SELLAS Life Sciences Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Feb 7, 2024 03:01PM Form SC 13G/A HH&L Acquisition Co. Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Feb 7, 2024 03:01PM Form SC 13G CAPRICOR THERAPEUTICS, Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Feb 7, 2024 03:00PM Form SC 13G Iron Horse Acquisitions Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Feb 7, 2024 02:01PM Form SC 13G/A Roadzen Inc. Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
View More Recent Stories View Older Stories